The Paquid epidemiological program on brain ageing, Neuroepidemiology, vol.11, pp.14-18, 1992. ,
The epidemiology of aluminum and Alzheimer's Disease: Aluminum and Alzheimer's Disease. The science that describes the link, p.441, 2001. ,
The pro-oxidant activity of aluminum, Free Radical Biology and Medicine, vol.36, issue.3, pp.380-387, 2004. ,
DOI : 10.1016/j.freeradbiomed.2003.11.017
Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain, The Lancet, vol.335, issue.8692, pp.747-750, 1990. ,
DOI : 10.1016/0140-6736(90)90868-6
Cerebral Blood Flow in Dementia, Archives of Neurology, vol.32, issue.9, pp.632-637, 1975. ,
DOI : 10.1001/archneur.1975.00490510088009
Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans, Neuroscience Letters, vol.317, issue.1, 2002. ,
DOI : 10.1016/S0304-3940(01)02403-X
Human Transferrin Polymorphism, Human Heredity, vol.37, issue.2, pp.65-81, 1987. ,
DOI : 10.1159/000153680
Intramuscular desferrioxamine in patients with Alzheimer's disease. The Lancet, pp.1304-1308, 1991. ,
Human transferrin (Tf): a single mutation at codon 570 determines Tf C1 or Tf C2 variant, Human Genetics, vol.100, issue.3-4, pp.457-458, 1997. ,
DOI : 10.1007/s004390050533
Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA, Clin Chem, vol.40, pp.24-29, 1994. ,
Relation between Aluminum Concentrations in Drinking Water and Alzheimer's Disease: An 8-year Follow-up Study, American Journal of Epidemiology, vol.152, issue.1, pp.59-66, 2000. ,
DOI : 10.1093/aje/152.1.59
A Review of Epidemiologic Studies on Aluminum and Silica in Relation to Alzheimer's Disease and Associated Disorders, Reviews on Environmental Health, vol.17, issue.2, pp.107-121, 2002. ,
DOI : 10.1515/REVEH.2002.17.2.107
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, vol.43, pp.1467-1472, 1993. ,
Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease, Neurotoxicology, vol.19, pp.209-214, 1998. ,